- Home
- NDLS vs SCNX Comparison
NDLS vs SCNX Comparison
Compare NDLS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- SCNX
- Stock Information
- Founded
- NDLS 1995
- SCNX 2010
- Country
- NDLS United States
- SCNX United States
- Employees
- NDLS N/A
- SCNX N/A
- Industry
- NDLS Restaurants
- SCNX Other Pharmaceuticals
- Sector
- NDLS Consumer Discretionary
- SCNX Health Care
- Exchange
- NDLS Nasdaq
- SCNX Nasdaq
- Market Cap
- NDLS 32.9M
- SCNX 14.4M
- IPO Year
- NDLS 2013
- SCNX 2020
- Fundamental
- Price
- NDLS $0.90
- SCNX $1.59
- Analyst Decision
- NDLS Strong Buy
- SCNX
- Analyst Count
- NDLS 2
- SCNX 0
- Target Price
- NDLS $3.00
- SCNX N/A
- AVG Volume (30 Days)
- NDLS 223.1K
- SCNX 180.9K
- Earning Date
- NDLS 08-06-2025
- SCNX 08-10-2025
- Dividend Yield
- NDLS N/A
- SCNX N/A
- EPS Growth
- NDLS N/A
- SCNX N/A
- EPS
- NDLS N/A
- SCNX N/A
- Revenue
- NDLS $495,670,000.00
- SCNX $146,901.00
- Revenue This Year
- NDLS $5.37
- SCNX N/A
- Revenue Next Year
- NDLS $0.68
- SCNX N/A
- P/E Ratio
- NDLS N/A
- SCNX N/A
- Revenue Growth
- NDLS N/A
- SCNX N/A
- 52 Week Low
- NDLS $0.55
- SCNX $0.69
- 52 Week High
- NDLS $1.83
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- NDLS 61.53
- SCNX N/A
- Support Level
- NDLS $0.66
- SCNX N/A
- Resistance Level
- NDLS $0.82
- SCNX N/A
- Average True Range (ATR)
- NDLS 0.08
- SCNX 0.00
- MACD
- NDLS 0.02
- SCNX 0.00
- Stochastic Oscillator
- NDLS 93.68
- SCNX 0.00
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.